- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05903066
TRansmural HEALING Definition i CroHns sykdom (TRENCH 1) (TRENCH 1)
Definisjon av transmural helbredelse ved Crohns sykdom - TRENCH1-studien
Multicenter prospective cross-sectional study of CD patients, its aim is the construction of an objective and reproducible system for evaluation of Transmural healing in Crohn's Disease (CD).
Primary objective : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Number of patients : 210 patients, in 14 sites (only one investigator per site), 15 patients per site, 5 patients per grade of transmural healing based on the appraisal of a local reader pair (a gastroenterologist and a radiologist).
Recruitment period : 2 years
Primary Endpoint : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Secondary Endpoints :
- To analyze intra- and inter-observer variability of radiological findings.
- To analyze intra- and inter-observer variability of TH definitions in CD.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Liège, Belgia, 4000
- CHU de Liège
-
-
-
-
-
Amiens, Frankrike, 80054
- CHU Amiens-Picardie (site Sud)
-
Bordeaux, Frankrike, 33600
- CHU de Bordeaux - Hôpital Haut-Lévêque
-
Boulogne-Billancourt, Frankrike, 92100
- APHP - Hôpital Ambroise Paré
-
Clermont-Ferrand, Frankrike, 63003
- CHU de Clermont-Ferrand - Hôpital d'Estaing
-
Lille, Frankrike, 59037
- CHRU de Lille - Hôpital Claude Huriez
-
Limoges, Frankrike, 87000
- CHU Limoges Dupuytren
-
Marseille, Frankrike, 13015
- AP-HM - Hôpital Nord
-
Montpellier, Frankrike, 34295
- CHU de Montpellier - Hôpital Saint Eloi
-
Nantes, Frankrike, 44093
- CHU de Nantes
-
Nîmes, Frankrike, 30029
- CHU de Nîmes - Hôpital Carémeau
-
Pierre-Bénite, Frankrike, 69475
- Hospices Civils de Lyon
-
Rennes, Frankrike, 35033
- CHU Rennes - Hôpital Pontchaillou
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients diagnosed with CD for more than 6 months with histological confirmation available in his medical record, with an indication for MRE based on routine clinical practice validated by the treating physician
Beskrivelse
Inclusion Criteria:
- ≥ 18 years of age
- Patient diagnosed with CD for more than 6 months with histological confirmation available in his medical record.
- Indication for MRE based on routine clinical practice validated by the treating physician
- Any CD treatment will be authorized, such as biologicals (infliximab, adalimumab, vedolizumab, ustekinumab…), or immunomodulators (azathioprine, 6-mercaptopurine, methotrexate…).
- The subjects sign and date a written, informed consent form and any required privacy authorization prior to the initiation of the study.
- A subject can be enrolled into the study only if the grade of TH (assessed by the LRP) corresponding to the subject is not already fulfilled.
Exclusion Criteria:
- Pregnancy during the study
- People unable to give consent (because of their physical or mental state)
- Absence of written consent
- Ulcerative colitis or unclassified IBD
- Specific postsurgical settings: ileoanal anastomosis, ileostomy or colostomy.
- Less than 3 evaluable ileocolic segments or more than 3 resected ileocolonic segments (not counting ileocecal valve)
- Severe obstructive symptoms
- Symptomatic intra-abdominal abscess
- Contraindication for MRI
- Isolated perianal disease without luminal location
- MRE images of poor quality, based on previously defined criteria
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Tidsramme: Day 1
|
An index (depth of remission) or score (grade of remission) will be constructed through multiple linear or logistic mixed regression models. |
Day 1
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Intra- and inter-observer variability of lesions observed per segment during MRE in CD
Tidsramme: Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
|
Intra- and inter-observer variability of depth and grade of global transmural healing in CD
Tidsramme: Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Sophie GEYL, CHU Limoge Dupuytren
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- GETAID-2022-03
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .